Berberine with Silymarin

Berberine is a key compound in metabolic health supplementation, as it contributes to the activation of protein kinase, which is involved in cardiovascular function, intestinal health, metabolic syndrome, and obesity.

Silymarin, an extract from the plant Silybum marianum (Milk Thistle), is a complex of flavonoids with antioxidant properties that protect the liver.

This makes this combination a unique option for those seeking a more comprehensive solution for glucose management and overall well-being.

The combination of Berberine with Silymarin and the white mulberry extract Reducose®, present in another Longevitas product called R-Glucose, offers an effective strategy for weight management. While R-Glucose helps control glucose spikes during meals, Berberine with Silymarin improves insulin sensitivity and helps regulate glucose metabolism, facilitating better management of blood sugar levels throughout the day and reducing fat storage.

The effectiveness of this product, designed by our Scientific Committee, is constantly measured by extensive diagnostic and analytical testing in the most prestigious Age Management clinics.

Each boat brings60 capsules

738 mg each, perfect to cover your needs for a month.You just need1 or 2 capsules daily before meals

, to optimize benefits.

When will I notice the benefits?Berberine with Silymarin is water-soluble, meaning it dissolves in water, which facilitates its absorption and excretion through urine if there is an excess..

For this reason, it needs to be consumed regularly, since the body does not retain it for long and only takes what it needs.

A positive impact will be noticed after 4 to 8 weeks of regular consumption, depending on the individual.

•Pure extract of Berberis root (Berberis vulgaris L.):A powerful natural ally for metabolic control.

•Concentrated Milk Thistle Seed Extract (Silybummarianum L.):With powerful antioxidant properties to protect and revitalize your liver.

•Vegetable coating agent (hydroxypropyl methylcellulose):For easy intake and optimal release of active ingredients.

•Magnesium salts of fatty acids:

2. Cicero, AFG, & Ertek, S. (2009). Berberine: Metabolic and cardiovascular effects in preclinical and clinical trials. Nutrition Reviews, 67(4), 188-196. https://doi.org/10.1111/j.1753-4887.2009.00190.x
   
3. Derosa, G., et al. (2016). A randomized, placebo-controlled study evaluating the effects of berberine, silymarin, and monacolin on lipid profile, glycemia, and liver function. Clinical Pharmacology: Advances and Applications, 8, 13–17. https://doi.org/10.2147/CPAA.S99989
   
4. Guo, Y., Li, F., Ma, X., & Cheng, X. (2018). The effects of berberine on glucose lipid metabolism, gut microbiota and liver and kidney functions in patients with metabolic syndrome. Journal of Translational Medicine, 16(1), 1-7. https://doi.org/10.1186/s12967-018-1435-1
   
5. Han, J., Lin, H., & Huang, W. (2011). Modulating gut microbiota as an anti-diabetic mechanism of berberine. Medical Science Monitor, 17(7), RA164-RA167. https://doi.org/10.12659/MSM.881222
   
6. López, V., et al. (2020). Berberine improves endothelial function by regulating eNOS, SOD, and inflammation in a preclinical model. Nutrients, 12(9), 2661. https://doi.org/10.3390/nu12092661
   
7. Bagherani, N., & Smoller, B.R. (2016). Applications of silymarin in dermatology: A comprehensive review. Journal of Clinical and Aesthetic Dermatology, 9(8), 41-52. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991643/
   
8. Huang, C., Zhang, Y., Gong, Z., & Sheng, X. (2021). Combination of berberine and silymarin in the treatment of non-alcoholic fatty liver disease. Journal of Cellular and Molecular Medicine, 25(6), 2648-2658. https://doi.org/10.1111/jcmm.16194
   
9. Mollazadeh, H., & Hosseinzadeh, H. (2014). The protective effect of silymarin against natural and chemical toxicities: A review. Iranian Journal of Basic Medical Sciences, 17(10), 802-822. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237980/
   
10. Gong, J., & Song, J. (2019). Berberine improves insulin sensitivity by inhibiting fat storage in HepG2 cells. Journal of Ethnopharmacology, 238, 111858. https://doi.org/10.1016/j.jep.2019.111858